5:57 PM
 | 
Oct 17, 2012
 |  BC Extra  |  Company News

Vivus seeking broader Qsymia distribution

Vivus Inc. (NASDAQ:VVUS) submitted to FDA an amendment to the existing REMS for Qsymia phentermine/topiramate that would allow select retail pharmacies...

Read the full 91 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >